DiaSorin Molecular: White Papers

For the detection of CMV in infants

The quality of treatment starts with diagnosis
DiaSorin Molecular is a part of the DiaSorin Group, an Italian multinational company and a global leader of in vitro diagnostics. For over 40 years, the group has been...

Enable early detection of congenital CMV infection
For over 40 years, DiaSorin Molecular has been developing, producing and commercialising diagnostic tests in a wide range of clinical areas including paediatrics, oncology, women’s...

The quality of treatment starts with diagnosis
DiaSorin Molecular manufactures and distributes molecular diagnostic products worldwide, helping laboratories to streamline workflow and improve patient management. The company is...


Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.